Middle East respiratory syndrome coronavirus (MERS-CoV)

  title={Middle East respiratory syndrome coronavirus (MERS-CoV)},
  author={M. Lal},
  • M. Lal
  • Published 6 May 2016
  • Medicine

Topics from this paper

Spatial variability of Middle East respiratory syndrome coronavirus survival rates and mortality hazard in Saudi Arabia, 2012–2019
MERS-CoV patient survival could be improved by implementing appropriate interventions for the elderly, those with comorbidities and non-HCW patients. Expand
COVID-19 extrapulmonary illness – special gastrointestinal and hepatic considerations
Various GI and hepatic manifestations with their prevalence, underlying pathophysiology with emphasis on stool positivity are summarized, including patients with diarrhea who have tested positive for viral RNA in the stool. Expand
Healthcare workers’ perspectives on healthcare-associated infections and infection control practices: a video-reflexive ethnography study in the Asir region of Saudi Arabia
Early introduction of training programmes in medical and nursing schools and video demonstrations of appropriate infection control practices during sterile procedures would be highly beneficial to HCWs, and intensive training programs for all the HCWs will significantly benefit the spread of outbreaks. Expand
Middle East respiratory syndrome coronavirus (MERS-CoV) — Surveillance and testing in North England from 2012 to 2019
The majority of patients had Influenza infection for which oseltamivir treatment was indicated and isolation warranted, and sputum samples were the most useful in diagnosing respiratory viruses with a 100% diagnostic yield from patients with multiple samples. Expand
Methods in protein engineering and screening : from rational design to directed evolution and beyond
The main theme presented in this chapter is molecular modeling and how computational tools can be applied to the post facto rationalization of laboratory evolution experiments (Sections 1-3) and examples of the predictive power of modern computational approaches are discussed. Expand
Public health risk and transmission route of Middle East respiratory syndrome (MERS): MERS coronavirus in dromedary camel
Middle East respiratory syndrome corona virus (MERS-CoV) is a novel enzootic beta origin corona virus which was described in September 2012 for the first time. According to the reports of differentExpand
Evidence for zoonotic origins of Middle East respiratory syndrome coronavirus
The evidence supporting a bat/camel origin of human MERS-CoV infection and current knowledge on the modes of camel-to-human transmission of MSPS are reviewed. Expand
Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers
All physicians and travelers to the Middle East should be aware of the new threat caused by MERS-CoV and follow CDC and WHO guidelines and those who develop ill health during their trip or soon after their return should seek medical care. Expand
Awareness of MERS-CoV among Staff Members of Prince Sultan Military Medical City in Riyadh, Saudi Arabia
Expatriates were majority and nurses were dominant which, necessitates Saudization of this sector, and HW were quite aware of the basic and emergent health policies during epidemic episodes of MERS-CoV. Expand
Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection
  • W. Park, L. Poon, +9 authors M. Oh
  • Medicine, Biology
  • International Journal of Infectious Diseases
  • 2018
It is suggested that MERS-CoV does not replicate well in the upper respiratory tract and was detected for up to 4 weeks after symptoms developed, which correlated with the detection of genomic RNA. Expand